Clinical Trial Update: ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completed Phase 1/2 results for a study combining proton beam therapy with anti-VEGF therapy in exudative age-related macular de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Proton beam therapy (proton beam therapy)
• anti-VEGF therapy

Snippet

Sponsor: University of California, Davis | Conditions: Exudative Age-related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-17